# Nektar Therapeutics: Form 8-K, filed Feb 10, 2026

- Company: [Nektar Therapeutics](/companies/nktr.md) (CIK 906709)
- Form: 8-K
- Filed: 2026-02-10
- Accepted by EDGAR: Feb 10, 2026, 21:21 ET
- Period: 2026-02-10
- Accession: 0001193125-26-044751
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/906709/000119312526044751/d40599d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/906709/000119312526044751/

## Items reported

- Item 7.01: Regulation FD disclosure

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/906709/000119312526044751/d40599d8k.htm

Filed Feb 10, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-044751. Last ingested by Listed: Oct 24, 2026, 15:00 ET. No prices; not investment advice.